Investigational Drug Information for PRX-03140
✉ Email this page to a colleague
What is the drug development status for PRX-03140?
PRX-03140 is an investigational drug.
There have been 4 clinical trials for PRX-03140.
The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2006.
The most common disease conditions in clinical trials are Alzheimer Disease, Disease, and Stress Disorders, Traumatic. The leading clinical trial sponsors are Epix Pharmaceuticals, Inc., Nanotherapeutics, Inc., and Ology Bioservices.
Summary for PRX-03140
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 11 |
| WIPO Patent Applications | 4 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 2 (2006-10-01) |
| Vendors | 3 |
Recent Clinical Trials for PRX-03140
| Title | Sponsor | Phase |
|---|---|---|
| Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder | Nanotherapeutics, Inc. | N/A |
| Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder | Ology Bioservices | N/A |
| Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease | Epix Pharmaceuticals, Inc. | Phase 2 |
Clinical Trial Summary for PRX-03140
Top disease conditions for PRX-03140
Top clinical trial sponsors for PRX-03140
US Patents for PRX-03140
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
